Johnson & Johnson's two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response in people over the age of one, according to two new papers published in The Lancet Infectious Diseases.
Sep 14, 2021
0
10
The Wits Vaccines and Infectious Diseases Analytical (VIDA) research unit conducted the phase 1B/2A clinical trial. The findings, published in The Lancet HIV on 17 August 2021, show that the AstraZeneca COVID-19 vaccine is ...
Sep 13, 2021
0
7
Two weeks after your second COVID-19 vaccine dose, the protective effects of vaccination will be at their highest. At this point, you're fully vaccinated. If you still get COVID-19 after this point, you've suffered a "breakthrough" ...
Sep 9, 2021
0
7
The first patients have been enrolled in a phase 1 randomized placebo-controlled clinical trial to study a therapeutic vaccine for opioid use disorder developed by researchers at the University of Minnesota Medical School.
Sep 7, 2021
0
15
Cuba on Monday became the first country in the world to vaccinate children from the age of two against COVID-19, using home-grown jabs not recognized by the World Health Organization.
Sep 7, 2021
0
8
US pediatric COVID hospitalizations have surged since Delta became predominant, but a new study that offers a first look at the relevant data suggests that fears the variant causes more severe disease are unfounded.
Sep 3, 2021
0
435
As the the COVID-19 vaccination campaign continues worldwide, research is ongoing to improve the vaccines available and develop new, effective, and innovative candidates to fight the pandemic and its variants and protect ...
Sep 1, 2021
0
8
British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a COVID-19 jab after positive early results, they announced Tuesday.
Aug 31, 2021
0
0
Influenza vaccination reduces the risk of all-cause death, myocardial infarction, or stent thrombosis at 12 months in hospitalized patients with myocardial infarction or high-risk coronary disease, according to late breaking ...
Aug 30, 2021
0
44
After evaluating data from clinical trials and millions of doses administered in the real world, the U.S. Food and Drug Administration (FDA) this week approved Pfizer-BioNTech's COVID-19 vaccine for individuals 16 years of ...
Aug 27, 2021
0
81
